News | August 09, 2023
Hikal posts Q1 FY 24 consolidated PAT at Rs. 6.92 Cr
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
Tiotropium (as bromide monohydrate) 18 micrograms powder for inhalation in capsule
Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
Hampton joins PCC from Accord Healthcare, where he was the President and responsible for accelerating the firm's growth strategy
The development and deployment of effective vaccines can help to mitigate the impact of pandemics, and we must prioritize research efforts to achieve this objective
Indian government seeks to promote collaboration with stakeholders and harness potential for achieving growth and development of sector
The acquisition of Medisol is part of Lupin's strategy to expand its presence in the EU
Q4 results was challenging driven by steep fall in CDMO revenues and higher upfront cost of Capex projects and R&D projects
The New State-of-Art OligoPilot 2000 solid-phase synthesizer adds cGMP manufacturing capacity to support and accelerate clinical and commercial oligonucleotide programs.
The audit is a pre-approval inspection for three products filed from the facility
Subscribe To Our Newsletter & Stay Updated
